4.6 Review

Involvement of galectin-1 in reproduction: past, present and future

期刊

HUMAN REPRODUCTION UPDATE
卷 20, 期 2, 页码 175-193

出版社

OXFORD UNIV PRESS
DOI: 10.1093/humupd/dmt040

关键词

galectin-1; pregnancy; angiogenesis; progesterone; cancer

资金

  1. Fritz Thyssen Stiftung [Az. 10.10.2.125]
  2. Bundesministerium fur Bildung und Forschung-Deutschen Zentrum fur Luft und Raumfahrt (Germany) [01DM1208 BMBF-DLR]
  3. Dutch Cancer Research Society [UM-2008-4101, VU2009-4358]
  4. CONICET, Argentina
  5. Charite, University Medicine Berlin, Germany

向作者/读者索取更多资源

After recognition of its pivotal contribution to fetomaternal tolerance, the study of galectin-1 (gal-1) functions in the context of pregnancy became an attractive topic in reproductive medicine. Despite considerable advances in the understanding of the immuno- and growth-regulatory properties of gal-1 at the fetalmaternal interface, many functional aspects of this lectin in reproduction are only emerging. The published literature was searched using Pubmed focusing on gal-1 signalling and functional properties at the maternalfetal interface, including data on its implication in pregnancy disorders and malignancies of the female reproductive system. Papers discussing animal and human studies were included. This review provides an overview of gal-1 functions during pregnancy, such as modulation of maternal immune responses and roles in embryo implantation and placentation. We also emphasize the role of gal-1 in key regulatory processes, including trophoblast migration, invasion, syncytium formation and expression of non-classical MHC class I molecules (HLA-G). In addition, we argue in favour of gal-1 pro-angiogenic properties, as observed in tumourigenesis and other pathological settings, and its implication in the angiogenesis process associated with early gestation. The involvement of gal-1 in the regulation of different processes during the establishment, development and maintenance of pregnancy could be described as unique. Gal-1 has emerged as an important lectin with major functions in pregnancy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Endocrinology & Metabolism

G Protein-Coupled Estrogen Receptor Correlates With Dkk2 Expression and Has Prognostic Impact in Ovarian Cancer Patients

Patricia Fraungruber, Till Kaltofen, Sabine Heublein, Christina Kuhn, Doris Mayr, Alexander Burges, Sven Mahner, Philipp Rathert, Udo Jeschke, Fabian Trillsch

Summary: The study found a correlation between Dkk2 and GPER expression in epithelial ovarian cancer, with combined high expression associated with improved overall survival. These findings suggest a potential prognostic impact and treatment strategies targeting estrogen and Wnt signaling interactions in ovarian cancer.

FRONTIERS IN ENDOCRINOLOGY (2021)

Article Cell Biology

The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro

Nan Han, Sabine Heublein, Udo Jeschke, Christina Kuhn, Anna Hester, Bastian Czogalla, Sven Mahner, Miriam Rottmann, Doris Mayr, Elisa Schmoeckel, Fabian Trillsch

Summary: The study found a positive correlation between GPER and H3K4me3 expression in ovarian cancer patients, with patients overexpressing both having improved overall survival. Activation of GPER led to increased H3K4me3 and p-ERK1/2 levels, as well as decreased cell proliferation and migration, while antagonizing GPER activity had opposite effects. The interaction between GPER and H3K4me3 is of prognostic significance and GPER agonists like G1 have potential as a therapeutic approach for ovarian cancer.
Article Medicine, General & Internal

Combined COX-2/PPARγ Expression as Independent Negative Prognosticator for Vulvar Cancer Patients

Nadine Ansorge, Christian Dannecker, Udo Jeschke, Elisa Schmoeckel, Doris Mayr, Helene H. Heidegger, Aurelia Vattai, Maximiliane Burgmann, Bastian Czogalla, Sven Mahner, Sophie Fuerst

Summary: The study found that the expression of COX-2 and PPAR gamma in vulvar cancer tissues is associated with survival rate, with cytoplasmic expression leading to reduced survival and nuclear expression associated with better survival. The combined expression of both COX-2 and PPAR gamma in the cytoplasm is considered an independent negative prognostic factor for vulvar cancer patients.

DIAGNOSTICS (2021)

Article Biochemistry & Molecular Biology

Acceleration of TAA-Induced Liver Fibrosis by Stress Exposure Is Associated with Upregulation of Nerve Growth Factor and Glycopattern Deviations

Catalina Atorrasagasti, Flavia Piccioni, Sophia Borowski, Irene Tirado-Gonzalez, Nancy Freitag, Maria Jose Cantero, Juan Bayo, Guillermo Mazzolini, Laura D. Alaniz, Sandra M. Blois, Mariana G. Garcia

Summary: Stress may contribute to liver fibrosis, and this study identified nerve growth factor as a crucial regulator in the stress-induced fibrogenesis signaling pathway. Blocking NGF can reduce liver fibrosis, while NGF treatment can accelerate the fibrotic process.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Immunology

Expression of the alternative splicing regulator Rbfox2 during placental development is differentially regulated in preeclampsia mouse models

Nancy Freitag, Yiran Xie, Lisa-Marie Adam, Sophia Borowski, Sandra M. Blois, Gabriela Barrientos

Summary: The study revealed the important role of alternative splicing regulator Rbfox2 in modulating trophoblast function during placental development, with implications for the pathogenesis of conditions like preeclampsia in pregnancy.

AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

Galectins in Endothelial Cell Biology and Angiogenesis: The Basics

Victor L. Thijssen

Summary: Angiogenesis, the process of new blood vessel growth, is tightly regulated and involves endothelial cells adopting different phenotypes to proliferate, migrate, and form tube-like structures. The galectin protein family is crucial for proper angiogenesis execution and has been linked to endothelial cell function and various steps of the angiogenesis cascade.

BIOMOLECULES (2021)

Article Oncology

Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden

Julia Femel, Luuk van Hooren, Melanie Herre, Jessica Cedervall, Falk Saupe, Elisabeth J. M. Huijbers, Danielle R. J. Verboogen, Matthias Reichel, Victor L. Thijssen, Arjan W. Griffioen, Lars Hellman, Anna Dimberg, Anna-Karin Olsson

Summary: Galectin-1 (Gal1) is a glycan-binding protein that promotes tumor progression through various mechanisms. Vaccination against Gal1 can generate high anti-Gal1 antibody levels and significantly impairs the growth of Gal1-expressing melanomas in mice. This is associated with improved tumor vasculature perfusion and increased infiltration of macrophages and cytotoxic T cells. Gal1 vaccination is a promising approach to enhance immunotherapeutic strategies for cancer therapy.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2022)

Article Biology

Chemokines modulate glycan binding and the immunoregulatory activity of galectins

Lucia Sanjurjo, Iris A. Schulkens, Pauline Touarin, Roy Heusschen, Ed Aanhane, Kitty C. M. Castricum, Tanja D. De Gruijl, Ulf J. Nilsson, Hakon Leffler, Arjan W. Griffioen, Latifa Elantak, Rory R. Koenen, Victor L. J. L. Thijssen

Summary: The study reveals that specific chemokine-galectin interactions can modulate the immunoregulatory function of galectins, affecting their glycan-binding activity and specificity. In particular, binding of CXCL4 changes the carbohydrate binding site of galectin-1, increasing its apoptotic activity on CD8(+) T cells.

COMMUNICATIONS BIOLOGY (2021)

Correction Oncology

Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden (Jan, 10.1007/s00262-021-03139-4, 2022)

Julia Femel, Luuk van Hooren, Melanie Herre, Jessica Cedervall, Falk Saupe, Elisabeth J. M. Huijbers, Danielle R. J. Verboogen, Matthias Reichel, Victor L. Thijssen, Arjan W. Griffioen, Lars Hellman, Anna Dimberg, Anna-Karin Olsson

CANCER IMMUNOLOGY IMMUNOTHERAPY (2022)

Article Chemistry, Medicinal

Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict PET Image Quality of Three Generations EGFR TKI in Advanced-Stage NSCLC Patients

I. H. Bartelink, E. A. van de Stadt, A. F. Leeuwerik, V. L. J. L. Thijssen, J. R. Hupsel, J. F. van den Nieuwendijk, I Bahce, M. Yaqub, N. H. Hendrikse

Summary: The developed physiological pharmacokinetic (PBPK) models accurately predicted the image quality and contrast of EGFR tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer. These models provide the potential for predicting the image quality of new tracers in the future.

PHARMACEUTICALS (2022)

Article Biochemistry & Molecular Biology

Metallated phthalocyanines and their hydrophilic derivatives for multi-targeted oncological photodynamic therapy

Lionel Mendes Dias, Mark J. de Keijzer, Daniel Ernst, Farangis Sharifi, Daniel J. de Klerk, Tony G. Kleijn, Emilie Desclos, Jakub A. Kochan, Lianne R. de Haan, Leonardo P. Franchi, Albert C. van Wijk, Enzo M. Scutigliani, Marcel H. Fens, Arjan D. Barendrecht, Jose E. B. Cavaco, Xuan Huang, Ying Xu, Weiwei Pan, Marjo J. den Broeder, Jan Bogerd, Rudiger W. Schulz, Kitty C. Castricum, Victor L. Thijssen, Shuqun Cheng, Baoyue Ding, Przemek M. Krawczyk, Michal Heger

Summary: The study developed a comprehensive tumor targeting and photosensitizer delivery platform. It was found that photodynamically active PSs effectively photosensitized cancer cells and non-cancerous cells without notable systemic toxicity. ZnPC and AlPC delivered by ITLs demonstrated strong tumor-killing capacity in human breast cancer xenografts.

JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2022)

Review Biochemistry & Molecular Biology

Galectokines: The Promiscuous Relationship between Galectins and Cytokines

Lucia Sanjurjo, Esmee C. Broekhuizen, Rory R. Koenen, Victor L. J. L. Thijssen

Summary: Galectins, a family of glycan-binding proteins, play a role in shaping the immune microenvironment by directly affecting immune cell activity and survival, as well as indirectly affecting immune response through binding to cytokines. Galectin-cytokine heterodimers, known as galectokines, add complexity to immune homeostasis regulation. This article summarizes current knowledge on galectokine formation and function, describes mechanisms by which galectokines shape the immune microenvironment, and discusses outstanding questions and challenges for future research on the role of galectokines in immunomodulation.

BIOMOLECULES (2022)

Review Oncology

Galectins in Esophageal Cancer: Current Knowledge and Future Perspectives

Tesfay M. Godefa, Sarah Derks, Victor L. J. L. Thijssen

Summary: Esophageal cancer is a disease with poor overall survival. Galectins, a family of glycan-binding proteins, have been linked to tumor angiogenesis and immunosuppression and identified as diagnostic and prognostic markers in several cancer types. However, their role in esophageal cancer is still poorly understood. This literature review summarizes the expression and potential functions of galectins in esophageal cancer and highlights the gaps in current knowledge. Further research is needed to better understand the diagnostic, prognostic, and predictive value of galectins in esophageal cancer and their functional role in tumor progression.

CANCERS (2022)

Article Oncology

A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT)

Charlotte Stroes, Sandor Schokker, Mohammed Khurshed, Stephanie O. van der Woude, Ron A. A. Mathot, Marije Slingerland, Judith de Vos-Geelen, Massimo Zucchetti, Cristina Matteo, Erik van Dijk, Bauke Ylstra, Victor Thijssen, Sarah Derks, Tesfay Godefa, Willemieke Dijksterhuis, Gerben E. Breimer, Otto M. van Delden, Rob H. A. Verhoeven, Sybren L. Meijer, Maarten F. Bijlsma, Hanneke W. M. van Laarhoven

Summary: The study evaluated the tolerability and efficacy of regorafenib and paclitaxel combination therapy in patients with advanced esophagogastric cancer refractory to first-line treatment. The results showed promising potential of this combination therapy in improving patient survival rates, while identifying potential negative predictive biomarkers for treatment response.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2022)

暂无数据